We have located links that may give you full text access.
Evaluation Studies
Journal Article
Early-stage diffuse unilateral subacute neuroretinitis: improvement of vision after photocoagulation of the worm.
Eye 2004 June
PURPOSE: To evaluate the visual outcome after direct laser photocoagulation of the worm in patients with early-stage diffuse unilateral subacute neuroretinitis (DUSN).
METHODS: We report on four patients with DUSN diagnosed in its early stage, in whom the worm was identified and destroyed by laser photocoagulation.
RESULTS: In all the four cases, resolution of the inflammatory multifocal lesions was achieved within 1 month of treatment. After that period and during follow-up (mean 11.5 months), visual acuity improved in three eyes and remained unchanged in one eye.
CONCLUSION: The diagnosis of DUSN in its early stage followed by prompt location and destruction of the worm by photocoagulation may improve vision of affected patients.
METHODS: We report on four patients with DUSN diagnosed in its early stage, in whom the worm was identified and destroyed by laser photocoagulation.
RESULTS: In all the four cases, resolution of the inflammatory multifocal lesions was achieved within 1 month of treatment. After that period and during follow-up (mean 11.5 months), visual acuity improved in three eyes and remained unchanged in one eye.
CONCLUSION: The diagnosis of DUSN in its early stage followed by prompt location and destruction of the worm by photocoagulation may improve vision of affected patients.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app